Crossover comparison of the pharmacokinetics of amlodipine and felodipine ER in hypertensive patients

International Journal of Clinical Pharmacology and Therapeutics

Volumn 35, Issue 11, 1997, Pages 514-518

  Videbaek, L M ^a   Jacobskn, I A ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Amlodipine; Felodipine; Pharmacokinetics

Indexed keywords

AMLODIPINE; FELODIPINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; SYSTOLIC BLOOD PRESSURE;

ADULT; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; AREA UNDER CURVE; BLOOD PRESSURE; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; FELODIPINE; FEMALE; HALF-LIFE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 0030720880     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Abernethy DR, Gutkowska J, Winterbottom LM 1990 Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: pharmacodynamics in relation to disposition. Clin Pharmacol Ther 48: 76-86
2. Ahnoff M 1984 Determination of felodipine in plasma by capillary gas chromatography with electron capture detection. J Pharm Biomed Anal 2: 519-526
3. Bainbridge AD, Herlihy O, Meredith PA, Elliott HL, 1993 A comparative assessment of amlodipine and felodipine ER: pharmacokinetic and pharmacodynamic indices. Eur J Clin Pharmacol 45: 425-430
4. Beresford AP, Macrae PV, Stopher DA, Wood BA 1987 Analysis of amlodipine in human plasma by gas chromatography. J Chromatogr 420: 178-183
5. Blychert E 1992 Felodipine pharmaacokinetics and plasma concentration vs effect relationships. Blood Pressure Suppl 2: 1-30
6. Blychert E, Edgar B, Elmfeldt D, Hedner T 1991 A population study of the pharmacokinetics of felodipine. Br J Clin Pharmacol 31: 15-24
7. Blychert K, Hedner T, Dahlof C, Elmfeldt D 1990 Plasma concentration-effect relationships of intravenous and extended-release oral felodipine in hypertensive patients. J Cardiovasc Pharmacol 15: 428-435
8. Darnis F, Poupon R 1993 Phannacokinetics and safely of single oral doses of amlodipine in patients with and without hepatic impairment: an open study. Int J Clin Pharmacol Res 13: 29-33
9. Dollery CT 1991 Clinical pharmacology of calcium antagonists. Am J Hypertiens 4: 88S-95S
10. Donnelly R, Meredith PA, Miller SH, Howie CA, Elliott HL 1993 Phar- macodynamic modeling of the amihypertcnsive response to am- lodipine. Clin Pharmacol Ther. 54: 303-310
11. Faulkner JK, McGibney D, Chasseaud LF, Periy JL, Taylor IW 1986 The pharmacokinelics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily. Br J Clin Pharmacol 22: 21-25
12. Hoeghulm A, Wiinberg N, Rasmussen E, Nielsen PE 1995 Office BP and ambulatory BP - a comparison between umlodipine and felodipine ER. J Hum Hypertens 9 (Suppl 8): 611-616
13. Koenig W 1993 Efficacy and tolerabilily of felodipine and amlodipine in the treatment of mild to moderate hypertension. Drug Invest 5: 200-205
14. Meredith PA, Ptrhff D, Manna G, Pickering T 1995 Blood pressure variability and its implications for antihypertensive therapy. Blood Pressure 4: 5-11
15. Prisant LM, Bottini B, DiPiro JT, Carr AA 1992 Novel drug-delivery systems for hypertension. Am J Med 93:45S-55S
16. Ueda S, Meredith PA, Howie CA, Elliott HL 1993 Long-acting calcium antagonists: amlodipine versus nifedipine gastrointestinal therapeutic system (GITS). J Hypertens 11 (Suppl 5): S332-S333
17. Williams DM, Cubeddu LX 1988 Amlodipine pharmacokinetics in healthy volunteers. J Clin Pharmacol 28: 990-994